CAT No: AAD-114
CAS No:90-46-0
Synonyms/Alias:9-Hydroxyxanthene; Xanthydrol; 9H-Xanthen-9-ol; 90-46-0; Xanthen-9-ol; 9-Xanthydrol; Xanthanol; Xanthene, hydroxy-; 9-Xanthenol; MFCD00005057; CHEMBL5204890; 7131M69IKF; NSC-4038; CCRIS 1640; NSC 4038; EINECS 201-996-1; BRN 0010395; Xanthrol; AI3-01536; Xanthydrol, 98%; Oprea1_119099; 5-17-04-00502 (Beilstein Handbook Reference); SCHEMBL521775; UNII-7131M69IKF; DTXSID8059009; NSC4038; WLN: T C666 BO IHJ IQ; BDBM50599588; STL283997; AKOS000120607; CS-W015654; AS-35115; NS00008884; X0055; EN300-19235; WLN: T C666 BO IVJ EG D1- AT6N DOTJ; A843556; Q4021716; Xanthydrol, for the detection of urea, >=99.0% (HPLC); InChI=1/C13H10O2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8,13-14
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.